This is the audio version of the second episode of the DIGITAL PATHOLOGY NEWSLETTER. that should have already landed in your inbox if you are on my digital pathology trailblazer list.
This is the audio version of the second episode of the DIGITAL PATHOLOGY NEWSLETTER. that should have already landed in your inbox if you are on my digital pathology trailblazer list.
Welcome to the second edition of the newsletter. We did have some tech problems. So I bet those of you who listened to the first part were like, when is she going to release the second part? Is it even coming well? Yes. I finally finalized it. And today in this newsletter episode, you will learn. That there are a lot of digital pathology trailblazers. We have a LinkedIn milestone to celebrate. What we need to be cautious about when implementing AI. How close are we to radiology and pathology by going directly from tissue to pathology image. And I'm going to tell you about the smallest and qTest microscope Kmart. I have unpacked so far. So let's start with me thanking you. I am thrilled to share that we've reached a remarkable milestone together. 10,000 subscribers on linked in. You are amazing. We made it and it's all. Thanks to your unwavering support, engagement and encouragement. Each of my digital pathology, trailblazers plays a pivotal role in shaping this community and your support with likes interactions in the comments, sharing of the posts and the messages I get from you in my LinkedIn inbox. They constantly inspire and motivate me to keep talking and keep creating content about digital pathology. Sometimes do myself. I sound like a broken record, but there are so many new digital pathology trailblazers, and there are so many topics to cover. Still. The. You guys motivate me to keep going. So thank you so much for trust and involvement. Your presence is what makes digital pathology place. This vibrant space where others want to share ideas and knowledge, and this sharing happens. Across different platforms, but LinkedIn. Is the platform that I think we as professionals use the most to talk about professional topics, which is what this platform is designed for. So, um, no one, there, there, but thank you so much. Eh, and growing on social media might seem like a funny goal to celebrate in the scientific and medical community. But what it means is that more and more people are actually accessing this content, not just as part of. Our literature research or lectures or some official education, but on a daily basis. So looking ahead, I'm excited to continue this journey with you. And I'm excited to be offering more content that resonates with your interests and aspirations with a strong focus on YouTube as well this year. So if you want to support me there. I will very, very much appreciate this is where most of the free, long form content will live. Uh, this is a platform or, you know, you can dive deeper into things so you can. Subscribe to the channel by clicking the link in the show notes. Regarding that interesting digital pathology research and developments. AI is of course at the forefront of any digital pathology endeavor. And I was totally inspired by my recent podcast guests, Dr. Richard Levinson. And the we're going to talk about the details of his podcast. In a minute. So this week I was diving deeper into the questions. What all could possibly go wrong when using AI and how it can be prevented. So he was a co author off a paper called. AI in pathology, what could possibly go wrong? And there is a link in the show notes to the original version of this paper. But if you cannot access it, Richard actually posted it on LinkedIn posted the author's version. So I have a link to that as well. And my favorite part of this paper is table one, Where he structures this topic of, uh, things going wrong in a yai. In a specific way. In the columns you will have. The first column are the challenges and the challenges are divided into challenges with data, with model development and with model deployment. Then in the second column, there is impact on AI and in the third column, Dar mitigation strategies. I am not going to be talking about what these components are because this newsletter would be like super long, but I already recorded a YouTube video. That's going to be coming out soon. Uh, walking you through everything that he has in the paper. And of course you can grab the paper anytime you want. I like this. Way of dividing it because this resembles their risk assessment strategies I'm familiar with from good laboratory practice, GLP validation approaches. So I was inspired. And like I told you, I recorded a YouTube video based on this paper. So stay tuned for that. So, as I mentioned, Richard is not only that author of the paper, AI, what could possibly go wrong, but he was also my podcast. The guest He is the vice chair of strategic technologies and department of pathology and laboratory medicine professor at the department of pathology and laboratory medicine at UC Davis. This podcast is already out. If you haven't watched it yet. There is a link in the show notes and it already resonated with almost 600 digital pathology trailblazers. Between different platforms. It was a pretty popular one, even though I only released it last week. So there's an interesting discussion going on on YouTube. And Richard is actually taking part in it as well. Responding to comments. About how useful and how necessary glassless pathology even is. This was the topic we covered. So before you had dared to join this discussion, let me give you a quick recap of what we covered in this episode. And, you know, you can skip forward to for already listened to this. But this episode revolved around two core teams that potential and challenges of AI in pathology, including ethical consideration implementation costs. And the need for diverse training datasets. Which is also a topic in his paper. And the IRS thing was the development of glassless pathology technologies like muse and Phoebe. Uh, which could revolutionize pathology by eliminating the need for glass. So basically by radiology using pathology, and I'm super excited about these new cutting edge technologies that can. Actually. Bring us from the shoe direct to image like radiology has the privilege to be working like that. Right. I am generally very enthusiastic about all those technologies and obviously reality and implementation will show if this is going to be the future. But for now, let me just be excited about it. And AI is part of both of the core teams. So we also discussed the importance of maintaining human expertise. In the face of advancing AI technologies, maintaining the human in the loop. And the financial and infrastructure are challenges of adopting new technologies in pathology. This is also a recurring theme whenever. Any digital pathology is showing up. And I guess it's going to be, so we're going to keep discussing it. So we both agreed that there is strong need for caution and informed. Decision-making when integrating AI into pathology practice. So I would love to hear from you, if you can imagine a glass as pathology lab, and are you as excited about this? The respective as I am or IVIG now. Totally absurd. Totally unnecessary, maybe for frozen sections, but not for anything else. I got away with this classless pathology. We're still sticking to glass. Whichever camp you're in. Let me know. And you can take part in the discussion on YouTube or LinkedIn. I'm going to be sharing a little clips from this episode with golden nuggets. And you can listen to it either on YouTube or to the full episode, or obviously here on the podcast. Regarding the educational resources. Uh, I mentioned that I had some tech problems. Yes. We were migrating our course hosting system. And my team and I totally underestimated the effort necessary to migrate everything. Uh, correctly, and it's not as fast as copy-paste. So bear with me. If you're trying to get access to the courses you already had access to. Just send me an email and I'm gonna help you, or I will have my team help you. And I already had a few trailblazers to each out because they couldn't access something. Let me know what, then I can fix it immediately. So, um, this work is still in progress, but the digital pathology start, our kit is up and running. This is that entry level course. So if you have someone who is just starting their digital pathology journey, you know, somebody who just joined a company or a pathologist who wants to. Just start their journey. Learn more. If you could share with them this resource, I would very, very much appreciate. So there's the link to the digital pathology starter kit in the show notes And I would love us to grow even more. And, uh, maybe soon celebrate some other milestone on another social media platform. But most of all, I would want to give. People who need this resource, this resource. So you can help. That would be fantastic. And what I'm exploring is also the topic of remote pathology work in more depth. So I've been working remotely as a toxicological pathologist for over three years now. I started with glass slides, shipped to my home and then switched to totally digital. So for me personally, there were not really any hurdles to overcome, but I'm aware that for other specialties, Uh, especially for MD specialties, this transitions might not be so easy. So I will be diving into their regulations and specific use cases. In my future content and actually in our spoiler alert, I already recorded the video is being edited right now. So once it's out, I'm gone, that of course shared with you. But I found another very useful resource from Dr. Giovanni. it is a past DPA webinar from last summer. It's titled remote sign-out myths and reality. So he's a digital pathology user. in the pandemic, he was like, totally signing out remotely. Now he's occasionally signing out remotely, but a very experienced, so this resource is available in the DPA member area. If you're already a member and you're logged in. The link in the show notes should work and you can just go straight there. And if not, once you remember, you can access it through the resources tab. And the webinar archive. Remote sign out, myths and reality. And. I will let you know, as soon as the video. Is out. I basically went through the CMS guidance About the remote signup and I'm super excited that they allowed it. That it was allowed. During the pandemic as the public health emergency. And now they said, okay, we can keep doing this, but the cool thing, or the cool thing is not on glass slides. So actually this is all only. Allowed for digital remote sign up and, you know, there are different. Uh, nuances about this basically. Yes, it is allowed. But on the, on digital. Regarding the cool digital pathology equipment. Recently a new sponsors, smart, immediate joined the digital pathology place supporters. So thank you so much and welcome smart Emedia. This helps us grow. This helps me create their content for the digital pathology trailblazers. And they specialize in digitizing the pathology workflow. Step-by-step. And they also send me the most compact and cute microscope Kmart I have ever seen. It's called pathogen. Zoom. So I've already unpacked it and we'll be installing everything today. I have a demo scheduled. So of course state, do you want for a detailed unboxing video that I'm already in the process of creating. And I know there's always a lag between when I first mentioned something and when I have the videos and tutorials ready, so this can be frustrating, but in the meantime while you're waiting to see the path to zoom in action, you can check the podcast episode I recorded With Dr. Martin He is the CEO of smart and media. This is a Germany based company. And you can learn more about their mission about patho zoom, And what smart in media is all about. And now they are supporting digital pathology place as well. So this is amazing. And a few quick bullet updates of what I'm up to. So I'm training for a half marathon in April. And this was my third week of targeted training. And actually the first one where I actually did everything I was supposed to do that week. And I ran all the miles that were on my plan. I did the prescribed workout. So, you know, Runner's no. Um, about that for non-runners workouts in running, or like specific ways of running, you have to run fast and slow than fast, whatever. Right. Uh, so. My point is. On the one hand, this feels good that I'm following the plan, but then. It took me three weeks to actually like, start really realizing it. And then I realized how easy it is to stop following it and just stop running altogether. You're just stopped. Right? It's so much easier than keep doing it. So I am focusing on one run at the time. Within the run on one mile at the time. And. I know exactly which race and training for, so I have the goal. But thinking about the end goal Make it. It's still a little bit intimidating. So I choose to focus on the daily and weekly progress. And if this wasn't obvious already it's of course applies to life as well. And to digital pathology, into everything, like it's so much easier to stop doing stuff and keep doing it. And with running, it's like, You were around there when you're running. You're not a runner anymore. When you stop running, then you used to be a runner. So. I don't know. I thought it was profound. And, uh, the other thing is fascinated by the idea of glassless pathology and microscopy. I ordered the full scope. What's the Foldscope, it's a foldable paper microscope invented at Stanford university and now used for education and making microscopy accessible. I'm a little bit obsessed with like little things that would help my kids see the microscopic world. Um, I don't know if they're even interested, but I like to believe they are. I first heard about it in 2019 at the global engaged digital pathogen AI conference. And then forgot about it. And they had a poster and I'm like, oh, such a cool idea. But then for like several years, I haven't heard about it. And now it's a company that really like focuses on educating. Classrooms. I don't know what mission they have, like teach billions of people about microscopy. Anyway. Now I'm hoping my kids will get interested in microscopy with this little gadget. And it's supposed to arrive tomorrow. So whenever I get it, I'm going to be posting social media content about this. About the full scope. So that's the newsletter for today. You should have it in your inbox. Because we were changing platforms, just check in spam. Uh, if it didn't by accident, land in spam and take me out of spam, I would very much appreciate it. And if you could head to YouTube. And listen to one of the episodes that you missed. That will help me tremendously. Every minute and every hour watched on YouTube helps us grow as well. So thank you so much. Thank you for the 10,000 on LinkedIn and I talk to you and the next step is out.